Captor Therapeutics Spolka Akcyjna reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was PLN 35.89 million compared to PLN 32.57 million a year ago. Basic loss per share from continuing operations was PLN 8.61 compared to PLN 7.89 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80 PLN | +0.25% | -.--% | -19.19% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.19% | 91.86M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- CTX Stock
- News Captor Therapeutics Spolka Akcyjna
- Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022